These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 22827975)

  • 41. Intratumoral c-Met expression is associated with vascular endothelial growth factor C expression, lymphangiogenesis, and lymph node metastasis in oral squamous cell carcinoma: implications for use as a prognostic marker.
    Zhao D; Wang SH; Feng Y; Hua CG; Zhao J; Tang XF
    Hum Pathol; 2011 Oct; 42(10):1514-23. PubMed ID: 21531000
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High expression levels of p27 correlate with lymph node status in a subset of advanced invasive breast carcinomas: relation to E-cadherin alterations, proliferative activity, and ploidy of the tumors.
    Kouvaraki M; Gorgoulis VG; Rassidakis GZ; Liodis P; Markopoulos C; Gogas J; Kittas C
    Cancer; 2002 May; 94(9):2454-65. PubMed ID: 12015771
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Traffic to lymph nodes of PC-3 prostate tumor cells in nude mice visualized using the luciferase gene as a tumor cell marker.
    Rubio N; Villacampa MM; Blanco J
    Lab Invest; 1998 Oct; 78(10):1315-25. PubMed ID: 9800957
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lymphatic spread of mesenchymal renal tumor to metastatic parathymic lymph nodes in rat.
    Rozsa D; Trencsenyi G; Kertai P; Marian T; Nagy G; Banfalvi G
    Histol Histopathol; 2009 Nov; 24(11):1367-79. PubMed ID: 19760586
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multiple-interactions among EMILIN1 and EMILIN2 N- and C-terminal domains.
    Bot S; Andreuzzi E; Capuano A; Schiavinato A; Colombatti A; Doliana R
    Matrix Biol; 2015 Jan; 41():44-55. PubMed ID: 25445627
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Integrin binding site within the gC1q domain orchestrates EMILIN-1-induced lymphangiogenesis.
    Capuano A; Pivetta E; Baldissera F; Bosisio G; Wassermann B; Bucciotti F; Colombatti A; Sabatelli P; Doliana R; Spessotto P
    Matrix Biol; 2019 Aug; 81():34-49. PubMed ID: 30408617
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Elastin microfibril interface-located protein 1, transforming growth factor beta, and implications on cardiovascular complications.
    Randell A; Daneshtalab N
    J Am Soc Hypertens; 2017 Jul; 11(7):437-448. PubMed ID: 28545768
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Loss of the extracellular matrix glycoprotein EMILIN1 accelerates Δ16HER2-driven breast cancer initiation in mice.
    Favero A; Segatto I; Capuano A; Mattevi MC; Rampioni Vinciguerra GL; Musco L; D'Andrea S; Dall'Acqua A; Gava C; Perin T; Massarut S; Marchini C; Baldassarre G; Spessotto P; Belletti B
    NPJ Breast Cancer; 2024 Jan; 10(1):5. PubMed ID: 38184660
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Distal motor neuropathy associated with novel EMILIN1 mutation.
    Iacomino M; Doliana R; Marchese M; Capuano A; Striano P; Spessotto P; Bosisio G; Iodice R; Manganelli F; Lanteri P; Orsini A; Baldassari S; Baratto S; Fruscione F; Prada V; Broda P; Tessa A; Bertocci G; Schenone A; Colombatti A; Minetti C; Santorelli FM; Zara F; Fiorillo C
    Neurobiol Dis; 2020 Apr; 137():104757. PubMed ID: 31978608
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The solution structure of EMILIN1 globular C1q domain reveals a disordered insertion necessary for interaction with the alpha4beta1 integrin.
    Verdone G; Doliana R; Corazza A; Colebrooke SA; Spessotto P; Bot S; Bucciotti F; Capuano A; Silvestri A; Viglino P; Campbell ID; Colombatti A; Esposito G
    J Biol Chem; 2008 Jul; 283(27):18947-56. PubMed ID: 18463100
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drosophila invasive tumors: a model for understanding metastasis.
    Woodhouse EC; Liotta LA
    Cell Cycle; 2004 Jan; 3(1):38-40. PubMed ID: 14657663
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Re: Shi et al. Protease-activated receptor 2 suppresses lymphangiogenesis and subsequent lymph node metastasis in a murine pancreatic cancer model. J Pathol 2014;234: 398-409.
    Rohan Z; Olejar T; Matej R
    J Pathol; 2015 May; 236(1):128-9. PubMed ID: 25488199
    [No Abstract]   [Full Text] [Related]  

  • 53. Authors' reply-Re: Shi et al. Protease-activated receptor 2 suppresses lymphangiogenesis and subsequent lymph node metastasis in a murine pancreatic cancer model. J Pathol 2014;234: 398-409.
    Shi K; Spek CA
    J Pathol; 2015 May; 236(1):130. PubMed ID: 25504568
    [No Abstract]   [Full Text] [Related]  

  • 54. Lymphatic invasion and metastasis.
    van de Velde C; Carr I
    Experientia; 1977 Jul; 33(7):837-43. PubMed ID: 330195
    [No Abstract]   [Full Text] [Related]  

  • 55. Studies on tumor variability. V. In vivo and in vitro investigations on H10Z tumor lymph node metastasis.
    Fadei L
    Oncology; 1975; 31(2):92-102. PubMed ID: 1208021
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Review on biofabrication and applications of heterogeneous tumor models.
    Liu T; Yao R; Pang Y; Sun W
    J Tissue Eng Regen Med; 2019 Nov; 13(11):2101-2120. PubMed ID: 31359625
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mutagenesis induced by the tumor microenvironment.
    Yuan J; Glazer PM
    Mutat Res; 1998 May; 400(1-2):439-46. PubMed ID: 9685702
    [TBL] [Abstract][Full Text] [Related]  

  • 58. EMILIN1 gene variant associated with polyneuropathy, language impairment, and motor dysfunction.
    Palumbo F; Moglia C; Romano A; Tessa A; Canosa A; Calvo A; Gallone S
    Am J Med Genet A; 2024 Jul; ():e63808. PubMed ID: 38963291
    [No Abstract]   [Full Text] [Related]  

  • 59. The extracellular matrix protein EMILIN1 silences the RAS-ERK pathway via α4β1 integrin and decreases tumor cell growth.
    Modica TME; Maiorani O; Sartori G; Pivetta E; Doliana R; Capuano A; Colombatti A; Spessotto P
    Oncotarget; 2017 Apr; 8(16):27034-27046. PubMed ID: 28177903
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Residues in the fructose-binding pocket are required for ketohexokinase-A activity.
    Ferreira JC; Villanueva AJ; Fadl S; Al Adem K; Cinviz ZN; Nedyalkova L; Cardoso THS; Andrade ME; Saksena NK; Sensoy O; Rabeh WM
    J Biol Chem; 2024 Aug; 300(8):107538. PubMed ID: 38971308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.